Adial Pharmaceuticals, Inc.
ADIL
$6.45
-$0.20-3.01%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -2,470.69% | -1.31% | -11.29% | 8.45% | 12.10% |
| Total Depreciation and Amortization | -200.00% | 0.00% | 0.00% | 200.00% | -200.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 21,365.54% | -32.83% | 43.29% | 0.49% | -10.65% |
| Change in Net Operating Assets | -469.59% | -44.57% | 232.53% | -1,870.90% | -103.41% |
| Cash from Operations | -294.60% | -21.73% | 27.75% | -4.79% | -10.36% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -100.00% |
| Cash from Investing | -- | -- | -- | -- | -100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 169.49% | -87.87% | 395.43% | -90.10% | 10,371.15% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 7,895.15% | -87.87% | 395.43% | -90.10% | 10,371.15% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,960.16% | -201.74% | 197.42% | -136.88% | 356.28% |